Genetic Predictors of Malignancy: a Literature Review
Open Access
- 22 May 2021
- journal article
- review article
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 11 (2) , 157-165
Abstract
The review covers recent research on cancer as a genetic disease manifesting both sporadically and in germline through variant genomic mutations or DNA rearrangements. This change can be point mutations, chromosomal aberrations or hypermethylation leading to DNA repair failures. Defects in tumour suppressor genes (BRCA1, BRCA2, CHEK2, PTCH1, etc.) underly hereditary predisposition to breast cancer (BC) and ovarian cancer (OC) due to genome instability. Studying somatic mutations is key to the understanding of carcinogenesis mechanisms and finding apt therapies. Heterogeneity of cancers renders the tumour mutation profiling uneasy. The treatment choice and efficacy in BC and OC depends on homologous recombination defects in tumour cells usually imposed by damaged BRCA1/2 genes. CHEK2- associated neoplasms account for most hereditary BCs linked to flaws in the DNA repair machinery. Overexpression of the PTCH1 protein is the target in breast, lung, ovarian, colonic cancers, etc.Genetic research has fundamentally altered our understanding of the aetiology and pathogenesis of human malignancy. The molecular cancer phenotype is of paramount importance in the disease prognosis and treatment personalisation.Keywords
This publication has 43 references indexed in Scilit:
- Spectrum and frequency of BRCA1, BRCA2, CHEK2, PALB2, RAD50 mutations in breast cancer patients in the Republic of BashkortostanKazan medical journal, 2020
- Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic reviewBreast Cancer Research, 2020
- Measuring Clonal Evolution in Cancer with GenomicsAnnual Review of Genomics and Human Genetics, 2019
- Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancerBreast Cancer Research and Treatment, 2017
- Phenotypic analysis of familial breast cancer: Comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancerEuropean Journal of Surgical Oncology, 2015
- Inherited Genetic Susceptibility to Breast CancerThe American Journal of Pathology, 2013
- Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriersBritish Journal of Cancer, 2013
- Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulationBreast Cancer Research and Treatment, 2012
- Genomic signature of BRCA1 deficiency in sporadic basal‐like breast tumorsGenes, Chromosomes and Cancer, 2010
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast CancerJournal of Clinical Oncology, 2010